Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions

Details for Australian Patent Application No. 2010282509 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Wessel, Thomas C.; Blight, Andrew

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010282509

PCT Pub. Number WO2011/019845

Priority 61/239,877 04.09.09 US; 61/233,069 11.08.09 US; 61/233,077 11.08.09 US

Filing date 11 August 2010

Wipo publication date 17 February 2011

International Classifications

A01N 43/40 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/019845 Priority application(s): WO2011/019845

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282516-Method and apparatus for expert quality control

2010282508-Transgenic animal for production of antibodies having minimal CDRs